Dr Reddys Labs Launches Generic Sapropterin Dihydrochloride Tablets
Dr Reddy'S Laboratories Ltd Announced The Launch Of A Generic Version Of Sapropterin Dihydrochloride Tablets, For Oral Use."We Are Pleased To Launch This Generic Version Of Sapropterin Dihydrochloride Tablets, For Oral Use, Illustrating Our Continued Commitment To Bring Affordable Generic Medicines To Market For Patients," Says Marc Kikuchi, Chief Executive Officer, North America Generics, Dr Reddy'S Laboratories."At The Same Time, This Product Demonstrates That We Are Actively Expanding The Breadth Of Our Portfolio With A Treatment For A Rare Disease. We Are Pleased To Provide Financial Support To Patients By Offering A Co-Pay Card Program For Eligible Patients, Details Will Be Available On Our Website," Added Kikuchi.Dr Reddy'S Sapropterin Dihydrochloride Tablets, 100 Mg Are Available In Bottle Count Sizes Of 120.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!